Cimzia 200 mg solution for injection in pre-filled syringe, SODIUM CHLORIDE
APHP200031
Phase 3 small_molecule active
Quick answer
Cimzia 200 mg solution for injection in pre-filled syringe, SODIUM CHLORIDE for Adult women with recurrent implantation failures (RIF) is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Adult women with recurrent implantation failures (RIF)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active